<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="MR-guided High-intensity Focused Ultrasound Treatment for Symptomatic Uterine Leiomyomata" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/mr-guided-high-intensity-focused-ultrasound-treatment-for-symptomatic-uterine-leiomyomata/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/mr-guided-high-intensity-focused-ultrasound-treatment-for-symptomatic-uterine-leiomyomata/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2011-07-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="MR-guided High-intensity Focused Ultrasound Treatment for Symptomatic Uterine Leiomyomata" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T02:43:55+00:00","datePublished":"2011-07-31T17:00:00+00:00","description":"Rationale and Objectives","headline":"MR-guided High-intensity Focused Ultrasound Treatment for Symptomatic Uterine Leiomyomata","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/mr-guided-high-intensity-focused-ultrasound-treatment-for-symptomatic-uterine-leiomyomata/"},"url":"https://clinicaltree.github.io/posts/mr-guided-high-intensity-focused-ultrasound-treatment-for-symptomatic-uterine-leiomyomata/"}</script><title>MR-guided High-intensity Focused Ultrasound Treatment for Symptomatic Uterine Leiomyomata | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>MR-guided High-intensity Focused Ultrasound Treatment for Symptomatic Uterine Leiomyomata</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>MR-guided High-intensity Focused Ultrasound Treatment for Symptomatic Uterine Leiomyomata</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1312131600" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Jul 31, 2011 </em> </span> <span> Updated <em class="" data-ts="1681094635" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Hyun S. Kim MD</a> </em>, <em> <a href="">Jun-Hyun Baik MD</a> </em>, <em> <a href="">Luu D. Pham MA</a> </em>, <em> <a href="">Michael A. Jacobs PhD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="1993 words"> <em>11 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>To evaluate the long-term clinical outcomes of magnetic resonance–guided high-intensity focused ultrasound (MR-g HIFU) treatments for symptomatic uterine leiomyomata.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Patients were recruited for a prospective study for MR-g HIFU treatments of symptomatic leiomyomata, with up to 3-year follow-up. The study was approved by the institutional review board and was Health Insurance Portability and Accountability Act–compliant. Clinical assessments were obtained at 3 months, 6 months, and 1, 2, and 3 years after MR-g HIFU, as well as uterine fibroid symptom severity scores (SSS) and health-related quality of life questionnaires (UFS-QOL). MR imaging was performed at each follow-up to assess the efficacy of the treatment at 6 months, 1 year, 2 years, and 3 years.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Fifty-one leiomyomata in 40 patients were treated. All patients were treated within the US Food and Drug Administration guidelines with leiomyomata localized on MR and treated with sonication. The mean baseline volume of treated leiomyomata was 336.9 cm 3 . The mean improvement scores for transformed SSS was 47.8 ( <em>P</em> &lt; .001) and for tUFS-QOL was 39.8 ( <em>P</em> &lt; .001) at 3 years. The mean volume decrease in treated leiomyomata was 32.0% ( <em>P</em> &lt; .001), and, in the uterus, the volume decrease was 27.7% ( <em>P</em> &lt; .001) at 3 years. There were no long-term complications.</p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Long-term follow-up data from MR-g HIFU treatments show sustained symptomatic relief among enrolled patients. Although the results are preliminary, MR-g HIFU for the treatment of uterine leiomyomata may result in acceptable long-term outcomes at 3 years.</p><p>Uterine leiomyomata occur in approximately 20%–50% of women of reproductive age . Symptoms are found in less than 50% of women; however, uterine leiomyomata can cause significant morbidity in pre- and perimenopausal women. Traditionally, gold standard therapy has been a hysterectomy. In the United States alone, hysterectomy is performed in more than 600,000 women annually and uterine leiomyomata account for approximately 30%–60% of all hysterectomies performed in middle-age women . More than $1.2 billion is spent each year associated with hysterectomies . The cost is even greater when accounted for the loss of women’s productivity during 6–8 weeks of recovery time after hysterectomy or myomectomy is considered.</p><p>Less invasive surgical techniques have been studied. Myomectomy is performed in 35,000–40,000 women for the treatment of uterine leiomyomata . Laparoscopic and hysteroscopic myomectomy have gained popularity as uterus-conserving surgeries . These less invasive techniques are restricted with regard to size and location of leiomyoma and still require general anesthesia. Laparoscopic thermoablative myolysis has shown significant variability in clinical efficacy .</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="patients"><span class="mr-2">Patients</span><a href="#patients" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="mr-g-hifu-techniques"><span class="mr-2">MR-g HIFU Techniques</span><a href="#mr-g-hifu-techniques" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MRguidedHighintensityFocusedUltrasoundTreatmentforSymptomaticUterineLeiomyomata/0_1s20S1076633211001966.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MRguidedHighintensityFocusedUltrasoundTreatmentforSymptomaticUterineLeiomyomata/0_1s20S1076633211001966.jpg" alt="Figure 1, (a) Baseline T 2 -weighed sagittal magnetic resonance (MR) image showing a dominant leiomyoma ( closed arrow ) with the patient in a prone position. Note the top of uterus at the level of upper end plate of L5 vertebral body ( open arrow ). (b) Baseline T 1 -weighted axial MR image after Gd contrast with the patient in a prone position showing homogeneous enhancement ( arrow ) in the leiomyoma. (c) T 1 -weighted axial MR image, with the patient in a prone position, immediately after MR-guided high-intensity focused ultrasound (MR-g HIFU) treatment demonstrates nonenhancing region ( closed arrow ) that corresponds to the treatment-effect area. Note the thick gel membrane ( open arrow ) with degassed water under the patient. (d) T 2 -weighted MR image, with the patient in a supine position 3 years after MR-g HIFU treatment. Note significant decrease in the dominant leiomyoma volume ( open arrow ). Note a closed arrow at the level of upper end plate of L5 vertebral body as a reference to compare to pre-MR-g HIFU treatment uterus and fibroid volumes." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="mr-imaging-parameters"><span class="mr-2">MR Imaging Parameters</span><a href="#mr-imaging-parameters" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="study-endpoints"><span class="mr-2">Study Endpoints</span><a href="#study-endpoints" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="statistical-analysis"><span class="mr-2">Statistical Analysis</span><a href="#statistical-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Clinical Assessment: tSSS and tQOL</p><p>tSSS tQOL Time Mean Value (95% CI) Mean Change (95% CI) Mean Value (95% CI) Mean Change (95% CI) Baseline 64.8 (59.1–70.6) 44.1 (37.7–50.6) 3 month 35.3 (29.3, 41.3) −29.5 (−37.8, −21.3) 68.8 (62.1–75.6) 24.6 (15.4–34.1) 6 month 32.2 (26.3–38.2) −32.6 (−40.9 to −24.3) 68.6 (61.9–75.4) 24.5 (15.2–33.9) 1 year 40.5 (32.5–48.7) −24.3 (−34.2 to −14.3) 68.7 (59.6–77.9) 24.6 (13.4–35.8) 2 year 18.0 (8.0–28.1) −46.8 (−58.4 to −35.2) 86.1 (74.8–97.5) 42.0 (28.9–51.2) 3 year 17.0 (8.9, 25.1) −47.8 (−57.7, −37.9) 83.9 (74.5–93.3) 39.8 (28.3–51.2)</p><p>QOL, quality of life; tQOL, transformed quality of life; tSSS, transformed symptom severity scale.</p><p>Table 2</p><p>Subgroup Analysis of Uterine Fibroid Symptom - Quality Of Life Questionnaire</p><p>Mean Concern Mean Activities Mean Energy Mean Control Mean Consciousness Mean Sexual Function Baseline 47.8 (39.6–56.0) 44.0 (36.3–51.7) 45.4 (38.0–52.8) 45.1 (36.9–53.3) 29.2 (20.2–38.2) 51.1 (42.3–59.8) 3 month 69.4 (60.9–78.0) 68.1 (60.1–76.1) 69.9 (62.2–77.6) 71.8 (63.3–80.4) 59.7 (50.4–69.1) 72.3 (63.2–81.3) 6 month 72.2 (63.6–80.6) 71.0 (63.1–79.0) 71.2 (63.5–78.9) 72.2 (63.6–80.7) 60.1 (50.8–69.5) 75.7 (66.7–84.8) 1 year 71.3 (59.7–82.8) 68.2 (57.4–79.1) 72.5 (62.1–82.9) 73.8 (62.1–85.4) 48.8 (36.1–61.5) 68.1 (55.7–80.5) 2 year 90.8 (76.4–105.1) 82.3 (75.9–102.7) 89.6 (76.7–102.5) 86.5 (72.1–100.9) 62.8 (47.0–78.6) 85.6 (70.2–100.9) 3 year 87.4 (75.5–99.2) 82.9 (71.8–94.0) 85.3 (74.6–96.1) 87.4 (75.5–99.3) 69.3 (56.2–82.4) 86.8 (74.1–99.5)</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 3</p><p>Volume Changes in Leiomyomata, Uterus, and Nonperfused Area within the Treatment Zone</p><p>Time Leiomyoma Volume (cm 3 ) Uterine Volume (cm 3 ) Nonperfused Leiomyoma Volume (cm 3 ) Mean Value (95% CI) Mean Change (95% CI), % Change Mean Value</p><p>(95% CI) Mean Change</p><p>(95% CI), % Change Mean Value</p><p>(95% CI) Mean Change</p><p>(95% CI), % Change Baseline 336.9 (295.2–378.6) 978.7 (925.1–1032.3) 7.1</p><p>(−11.6 to 25.8), 2.1% Immediate posttreatment 108.1 (87.5–128.7), 32.1% 101.0 (76.6–125.5),</p><p>1422.5% 6 month 273.6 (229.3–318.0) −63.3 (−96.5 to −30.0), −18.7% 875.0 (819.2–930.8) −103.7 (−159.4 to −47.9), −10.5% 45.0 (25.2–64.9), 16.5% 40.0 (14.1–61.9),</p><p>563.4% 1 year 249.7 (207.7–291.7) −87.2 (−127.7 to −46.7), −25.8% 835.9 (782.4–889.5) −142.7 (−209.8 to −75.7), −14.5% 39.4 (14.9–63.8), 15.8% 32.3 (3.9–60.7),</p><p>454.9% 2 year 243.1 (192.2, 293.9) −93.9 (−142.5 to −45.2), −27.6% 762.9 (687.9–837.9) −215.7 (−296.4 to −135.1), −22.0% 26.6 (−4.2 to 57.5), 10.9% 19.6(−15.2 to 54.4),</p><p>276.1% 3 year 228.4 (171.9–284.8) −108.5 (165.5 to −51.4), −32.0% 707.3 (622.2–792.4) −271.4 (−365.1 to −177.7), −27.7% 30.5 (−7.0 to 68.0), 13.4% 23.4 (−17.5 to 64.3),</p><p>329.6%</p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MRguidedHighintensityFocusedUltrasoundTreatmentforSymptomaticUterineLeiomyomata/1_1s20S1076633211001966.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MRguidedHighintensityFocusedUltrasoundTreatmentforSymptomaticUterineLeiomyomata/1_1s20S1076633211001966.jpg" alt="Figure 2, (a) Treated leiomyoma volume changes and uterus volume changes over the 3 years after magnetic resonance–guided high intensity focused ultrasound (MR-g HIFU). (b) Nonperfused volume changes over the 3 years after MR-g HIFU." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MRguidedHighintensityFocusedUltrasoundTreatmentforSymptomaticUterineLeiomyomata/2_1s20S1076633211001966.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MRguidedHighintensityFocusedUltrasoundTreatmentforSymptomaticUterineLeiomyomata/2_1s20S1076633211001966.jpg" alt="Figure 3, Kaplan-Meier estimates of the time elapsed until the alternative treatments after the initial magnetic resonance–guided high intensity focused ultrasound." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="conclusion"><span class="mr-2">Conclusion</span><a href="#conclusion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Buttram V.C.J., Reiter R.C.: Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril 1981; 36: pp. 433-445.</p><li><p>2. Vollenhoven B.J., Lawrence A.S., Healy D.L.: Uterine fibroids: a clinical review. Br J Obstet Gynaecol 1990; 97: pp. 285-298.</p><li><p>3. Bernstein S.J., Fiske M.E., McGlynn E.A., et. al.: Hysterectomy: a review of the literature on indications, effectiveness, and risks.1998.RandSanta Monica, CA</p><li><p>4. Lepine L., Hillis S., Marchbanks P., et. al.: Hysterectomy surveillance—United States, 1980–1993. MMWR CDC Surveill Summ 1997; 46: pp. 1-15.</p><li><p>5. Xhao S., Wong J., Arguelles L.: Hospitalization costs associated with leiomyoma. Clin Ther 1999; 21: pp. 563-575.</p><li><p>6. National Center for Health Statistics: Ambulatory and Inpatient Procedures in the United States. DHHS Publication No. (PHS) 99-1710 1998;</p><li><p>7. Stewart E.: Uterine fibroids. Lancet 2001; 357: pp. 293.</p><li><p>8. Goldfarb H.: Myoma coagulation (myolysis). Obstet Gynecol Clin North Am 2000; 27: pp. 421-430.</p><li><p>9. Zreik T., Rutherford T., Palter S., et. al.: Cryomyolysis, a new procedure for the conservative treatment of uterine fibroids. J Am Assoc Gynecol Laparosc 1998; 5: pp. 33-38.</p><li><p>10. Spies J.B., Ascher S.A., Roth A.R., et. al.: Uterine artery embolization for leiomyomata. Obstet Gynecol 2001; 98: pp. 29-34.</p><li><p>11. Spies J.B., Myers E.R., Worthington-Kirsch R., et. al.: The FIBROID Registry: symptom and quality-of-life status 1 year after therapy. Obstet Gynecol 2005; 106: pp. 1309-1318.</p><li><p>12. Pron G., Bennett J., Common A., et. al.: Technical results and effects of operator experience on uterine artery embolization for fibroids: the Ontario Uterine Fibroid Embolization Trial. J Vasc Interv Radiol 2003; 14: pp. 545-554.</p><li><p>13. Pron G., Mocarski E., Bennett J., et. al.: Tolerance, hospital stay, and recovery after uterine artery embolization for fibroids: the Ontario Uterine Fibroid Embolization Trial. J Vasc Interv Radiol 2003; 14: pp. 1243-1250.</p><li><p>14. Spies J.B., Spector A., Roth A.R., et. al.: Complications after uterine artery embolization for leiomyomas. Obstet Gynecol 2002; 100: pp. 873-880.</p><li><p>15. Kim H.S., Thonse V.R., Judson K., et. al.: Utero-ovarian anastomosis—histopathologic correlation after uterine artery embolization with or without ovarian artery embolization. J Vasc Interv Radiol 2007; 18: pp. 31-39.</p><li><p>16. Kim H.S., Tsai J., Lee J.M., et. al.: Effects of utero-ovarian anastomoses on basal follicle-stimulating hormone level change after uterine artery embolization with tris-acryl gelatin Microspheres. J Vasc Interv Radiol 2006; 17: pp. 965-971.</p><li><p>17. Kim H.S., Tsai J., Jacobs M.A., et. al.: Percutaneous image-guided radiofrequency thermal ablation for large symptomatic uterine leiomyomata after uterine artery embolization: a feasibility and safety study. J Vasc Interv Radiol 2007; 18: pp. 41-48.</p><li><p>18. Cowan B., Sewell P., Howard J., et. al.: Interventional magnetic resonance imaging cryotherapy of uterine fibroid tumors: preliminary observation. Am J Obstet Gynecol 2002; 186: pp. 1183.</p><li><p>19. Sakuhara Y., Shimizu T., Kodama Y., et. al.: Magnetic resonance-guided percutaneous cryoablation of uterine fibroids: early clinical experiences. Cardiovasc Intervent Radiol 2006; 29: pp. 552-558.</p><li><p>20. Hindley J.T., Law P.A., Hickey M., et. al.: Clinical outcomes following percutaneous magnetic resonance image guided laser ablation of symptomatic uterine fibroids. Hum. Reprod 2002; 17: pp. 2737-2741.</p><li><p>21. Hindley J., Gedroyc W.M., Regan L., et. al.: MRI guidance of focused ultrasound therapy of uterine fibroids: early results. Am J Roentgenol 2004; 183: pp. 1713-1719.</p><li><p>22. Jacobs M.A., Herskovits E.H., Kim H.S.: Uterine fibroids: diffusion-weighted MR imaging for monitoring therapy with focused ultrasound surgery—preliminary study. Radiology 2005; 236: pp. 196-203.</p><li><p>23. Stewart E.A., Gostout B., Rabinovici J., et. al.: Sustained relief of leiomyoma symptoms by using focused ultrasound surgery. Obstet Gynecol 2007; 110: pp. 279-287.</p><li><p>24. Stewart E.A., Rabinovici J., Tempany C.M., et. al.: Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril 2006; 85: pp. 22-29.</p><li><p>25. Zowall H., Cairns J.A., Brewer C., et. al.: Cost-effectiveness of magnetic resonance-guided focused ultrasound surgery for treatment of uterine fibroids. BJOG Int J Obstet Gynaecol 2008; 115: pp. 653-662.</p><li><p>26. Spies J.B., Coyne K., Guaou N.G., et. al.: The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol 2002; 99: pp. 290-300.</p><li><p>27. Goodwin S.C., Bonilla S.C., Sacks D., et. al.: Reporting standards for uterine artery embolization for the treatment of uterine leiomyomata. J Vasc Interv Radiol 2003; 14: pp. 467-476.</p><li><p>28. Diggle P., Heagerty P., Liang K.-Y., et. al.: Analysis of longitudinal data.2002.Oxford University Press2nd ed. Oxford, UK</p><li><p>29. Goodwin S.C., Spies J.B., Worthington-Kirsch R., et. al.: Uterine artery embolization for treatment of leiomyomata: long-term outcomes from the FIBROID Registry. Obstet Gynecol 2008; 111: pp. 22-33.</p><li><p>30. Kim H.S., Paxton B.E., Lee J.M.: Long-term efficacy and safety of uterine artery embolization in young patients with and without uteroovarian anastomoses. J Vasc Interv Radiol 2008; 19: pp. 195-200.</p><li><p>31. Spies J.B., Bruno J., Czeyda-Pommersheim F., et. al.: Long-term outcome of uterine artery embolization of leiomyomata. Obstet Gynecol 2005; 106: pp. 933-939.</p><li><p>32. Banovac F., Ascher S.M., Jones D.A., et. al.: Magnetic resonance imaging outcome after uterine artery embolization for leiomyomata with use of tris-acryl gelatin microspheres. J Vasc Interv Radiol 2002; 13: pp. 681-688.</p><li><p>33. Kim H.S., Tsai J., Patra A., et. al.: Effects of utero-ovarian anastomoses on clinical outcomes and repeat intervention rates after uterine artery embolization. J Vasc Interv Radiol 2006; 17: pp. 783-789.</p><li><p>34. Pelage J.P., Guaou N.G., Jha R.C., et. al.: Uterine fibroid tumors: long-term MR imaging outcome after embolization. Radiology 2004; 230: pp. 803-809.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-18/'>Volume 18</a>, <a href='/categories/issue-8/'>Issue 8</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=MR-guided%20High-intensity%20Focused%20Ultrasound%20Treatment%20for%20Symptomatic%20Uterine%20Leiomyomata%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fmr-guided-high-intensity-focused-ultrasound-treatment-for-symptomatic-uterine-leiomyomata%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=MR-guided%20High-intensity%20Focused%20Ultrasound%20Treatment%20for%20Symptomatic%20Uterine%20Leiomyomata%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fmr-guided-high-intensity-focused-ultrasound-treatment-for-symptomatic-uterine-leiomyomata%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fmr-guided-high-intensity-focused-ultrasound-treatment-for-symptomatic-uterine-leiomyomata%2F&text=MR-guided%20High-intensity%20Focused%20Ultrasound%20Treatment%20for%20Symptomatic%20Uterine%20Leiomyomata%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/a-guide-to-stereoscopic-3d-displays-in-medicine/"><div class="card-body"> <em class="small" data-ts="1312131600" data-df="ll" > Jul 31, 2011 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>A Guide to Stereoscopic 3D Displays in Medicine</h3><div class="text-muted small"><p> Stereoscopic displays can potentially improve many aspects of medicine. However, weighing the advantages and disadvantages of such displays remains difficult, and more insight is needed to evaluate...</p></div></div></a></div><div class="card"> <a href="/posts/a-low-tube-voltage-technique-reduces-the-radiation-dose-at-retrospective-ecg-gated-cardiac-computed/"><div class="card-body"> <em class="small" data-ts="1312131600" data-df="ll" > Jul 31, 2011 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>A Low Tube Voltage Technique Reduces the Radiation Dose at Retrospective ECG-gated Cardiac Computed Tomography for Anatomical and Functional Analyses</h3><div class="text-muted small"><p> Rationale and Objectives To investigate the effect of low-tube-voltage technique on a cardiac computed tomography (CT) for coronary arterial and cardiac functional analyses and radiation dose in s...</p></div></div></a></div><div class="card"> <a href="/posts/correlation-of-immunohistologic-and-perfusion-vascular-parameters-with-mr-contrast-enhancement-using/"><div class="card-body"> <em class="small" data-ts="1312131600" data-df="ll" > Jul 31, 2011 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Correlation of Immunohistologic and Perfusion Vascular Parameters with MR Contrast Enhancement Using Image-guided Biopsy Specimens in Gliomas</h3><div class="text-muted small"><p> Rationale and Objectives The purpose of this study was to correlate the status of magnetic resonance contrast enhancement with immunohistologic vascular parameters such as microvascular cellular p...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/molecular-imaging-of-malignant-tumor-metabolism/" class="btn btn-outline-primary" prompt="Older"><p>Molecular Imaging of Malignant Tumor Metabolism</p></a> <a href="/posts/quantification-of-epicardial-adipose-tissue/" class="btn btn-outline-primary" prompt="Newer"><p>Quantification of Epicardial Adipose Tissue</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
